Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 241
7
Diseases
62
Unique genes
0.079
Avg. similarity score
Polyneuropathy
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Polyneuropathy
Cerebellar atrophy
Dysarthria
Congenital cataract microcephaly intellectual disability syndrome
Congenital cerebellar hypoplasia
Sterol carrier protein 2 deficiency
Troyer syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Polyneuropathy | 4 | 4 | 24 |
| Cerebellar atrophy | 3 | 3 | 30 |
| Dysarthria | 3 | 3 | 22 |
| Congenital cataract microcephaly intellectual disability syndrome | 1 | 1 | 1 |
| Congenital cerebellar hypoplasia | 1 | 1 | 1 |
| Sterol carrier protein 2 deficiency | 1 | 1 | 1 |
| Troyer syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BIVM-ERCC5 | 3 / 7 | Cerebellar atrophy, Dysarthria, Polyneuropathy |
| ERCC5 | 3 / 7 | Cerebellar atrophy, Dysarthria, Polyneuropathy |
| PNPLA6 | 3 / 7 | Cerebellar atrophy, Dysarthria, Polyneuropathy |
| SMC1A | 3 / 7 | Cerebellar atrophy, Dysarthria, Polyneuropathy |
| CACNA1A | 2 / 7 | Cerebellar atrophy, Dysarthria |
| DNMT1 | 2 / 7 | Cerebellar atrophy, Dysarthria |
| DYNC1H1 | 2 / 7 | Cerebellar atrophy, Polyneuropathy |
| HARS1 | 2 / 7 | Cerebellar atrophy, Dysarthria |
| MED25 | 2 / 7 | Congenital cataract microcephaly intellectual disability syndrome, Polyneuropathy |
| OXR1 | 2 / 7 | Cerebellar atrophy, Congenital cerebellar hypoplasia |
| SCP2 | 2 / 7 | Polyneuropathy, Sterol carrier protein 2 deficiency |
| SPART | 2 / 7 | Dysarthria, Troyer syndrome |
| SPG7 | 2 / 7 | Dysarthria, Polyneuropathy |
| TBC1D24 | 2 / 7 | Cerebellar atrophy, Dysarthria |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Adenylate cyclase activating pathway | Reactome | 2 / 10 | 38.7× | 1.15e-3 | 1.51e-2 ✓ sig. |
| Adenylate cyclase inhibitory pathway | Reactome | 2 / 14 | 27.7× | 2.29e-3 | 2.52e-2 ✓ sig. |
| Parkinson disease | KEGG | 6 / 268 | 4.3× | 2.52e-3 | 2.71e-2 ✓ sig. |
| Retrograde endocannabinoid signaling | KEGG | 4 / 149 | 5.2× | 7.27e-3 | 5.61e-2 |
| SUMOylation of DNA damage response and repair proteins | Reactome | 3 / 77 | 7.5× | 7.31e-3 | 5.62e-2 |
| Phagosome | KEGG | 4 / 155 | 5.0× | 8.34e-3 | 6.12e-2 |
| Respiratory electron transport | Reactome | 3 / 83 | 7.0× | 8.98e-3 | 6.42e-2 |
| Amyotrophic lateral sclerosis | KEGG | 6 / 368 | 3.2× | 1.15e-2 | 7.48e-2 |
| Morphine addiction | KEGG | 3 / 91 | 6.4× | 1.15e-2 | 7.49e-2 |
| Detoxification of Reactive Oxygen Species | Reactome | 2 / 34 | 11.4× | 1.32e-2 | 8.07e-2 |
| FCGR3A-mediated IL10 synthesis | Reactome | 2 / 35 | 11.1× | 1.40e-2 | 8.35e-2 |
| Glycerophospholipid catabolism | Reactome | 1 / 3 | 64.6× | 1.54e-2 | 8.85e-2 |
| Selenocysteine synthesis | Reactome | 1 / 3 | 64.6× | 1.54e-2 | 8.85e-2 |
| Glycogen storage disease type IV (GBE1) | Reactome | 1 / 3 | 64.6× | 1.54e-2 | 8.85e-2 |
| Breakdown of the nuclear lamina | Reactome | 1 / 3 | 64.6× | 1.54e-2 | 8.85e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| response to hyperoxia | GO:0055093 | 3 / 14 | 64.6× | 1.23e-5 | 6.14e-4 ✓ sig. |
| bile acid metabolic process | GO:0008206 | 3 / 17 | 53.2× | 2.29e-5 | 9.96e-4 ✓ sig. |
| nuclear pore localization | GO:0051664 | 2 / 5 | 121× | 1.08e-4 | 3.19e-3 ✓ sig. |
| negative regulation of cellular response to oxidative stress | GO:1900408 | 2 / 5 | 121× | 1.08e-4 | 3.19e-3 ✓ sig. |
| adult walking behavior | GO:0007628 | 3 / 34 | 26.6× | 1.93e-4 | 4.94e-3 ✓ sig. |
| response to axon injury | GO:0048678 | 3 / 37 | 24.4× | 2.49e-4 | 5.91e-3 ✓ sig. |
| DNA repair | GO:0006281 | 7 / 420 | 5.0× | 4.67e-4 | 9.14e-3 ✓ sig. |
| adenylate cyclase-activating dopamine receptor signaling pathway | GO:0007191 | 2 / 11 | 54.8× | 5.84e-4 | 1.07e-2 ✓ sig. |
| intracellular cholesterol transport | GO:0032367 | 2 / 13 | 46.4× | 8.25e-4 | 1.33e-2 ✓ sig. |
| cerebellar Purkinje cell differentiation | GO:0021702 | 2 / 14 | 43.1× | 9.61e-4 | 1.47e-2 ✓ sig. |
| base-excision repair, gap-filling | GO:0006287 | 2 / 14 | 43.1× | 9.61e-4 | 1.47e-2 ✓ sig. |
| removal of superoxide radicals | GO:0019430 | 2 / 15 | 40.2× | 1.11e-3 | 1.61e-2 ✓ sig. |
| proton motive force-driven mitochondrial ATP synthesis | GO:0042776 | 3 / 64 | 14.1× | 1.25e-3 | 1.74e-2 ✓ sig. |
| sterol transport | GO:0015918 | 2 / 17 | 35.5× | 1.43e-3 | 1.87e-2 ✓ sig. |
| aerobic respiration | GO:0009060 | 3 / 68 | 13.3× | 1.49e-3 | 1.91e-2 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cerebellar atrophy | Dysarthria | 0.178 | 8 | 2.35e-17 | 4.12e-16 ✓ sig. |
| Dysarthria | Polyneuropathy | 0.119 | 5 | 1.53e-10 | 1.58e-9 ✓ sig. |
| Cerebellar atrophy | Polyneuropathy | 0.100 | 5 | 8.19e-10 | 7.89e-9 ✓ sig. |
| Dysarthria | Troyer syndrome | 0.043 | 1 | 1.43e-3 | 2.21e-3 ✓ sig. |
| Congenital cataract microcephaly intellectual disability syndrome | Polyneuropathy | 0.040 | 1 | 1.56e-3 | 2.36e-3 ✓ sig. |
| Polyneuropathy | Sterol carrier protein 2 deficiency | 0.040 | 1 | 1.56e-3 | 2.36e-3 ✓ sig. |
| Cerebellar atrophy | Congenital cerebellar hypoplasia | 0.032 | 1 | 1.95e-3 | 2.81e-3 ✓ sig. |